Health | Science | Technology | Space | Sports | Entertainment | Mobile | Games | Economy | Politics | Movies | Music | [Top News]

Posts tagged: initiating

A Mechanism Explaining How Tumor Cells Spread To Nearby Organs And Structures, Initiating Metastasis

March 8, 2012
Metastasis is responsible for 90% of deaths in patients with cancer. Understanding the mechanisms responsible for this process is one of the top goals of cancer research. The metastatic process involves a series of steps chained where the primary tumour invades surrounding tissues and ends spreading throughout the body. Ones ...

Injecting MWCNTs can kill tumor initiating breast cancer stem cells

February 10, 2012
Wake Forest Baptist Medical Center researchers have again proven that injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second laser treatment can kill them.

Infection rate drops at Nebraska hospital after initiating new protocols

June 28, 2011
Nurses, occupational and physical therapists, case managers and education staff, all working together at a 300-bed Nebraska rehabilitation hospital, have successfully implemented a team approach to dramatically reduce infections from urinary catheters, the most prevalent type of infection acquired in healthcare settings.

Sanofi’s Investigational Semuloparin In Cancer Patients Initiating Chemotherapy Shows A 64% Risk Reduction In Life-Threatening Venous Thrombo-Embolism

June 6, 2011
Sanofi (EURONEXT: SAN and NYSE: SNY) announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%[i], meeting ...

Patients Initiating Chemotherapy With Semuloparin Have 64 % Risk Reduction In Venous Thrombo-Embolism

June 5, 2011
Sanofi announced today results of the pivotal SAVE-ONCO study which demonstrated that, in cancer patients initiating a chemotherapy regimen, investigational semuloparin significantly reduced the risk of the composite of symptomatic-deep vein thromboembolism (DVT), non-fatal pulmonary embolism (PE) or venous thromboembolism (VTE)-related death by 64%[i], meeting the study primary endpoint ...

Pancreatic cancer study reveals mechanism initiating disease, in mice

March 12, 2010
UCSF scientists have discovered how a mutated gene known as Kras is able to hijack mouse cells damaged by acute pancreatitis, putting them on the path to becoming pancreatic cancer cells.

Pancreatic cancer study reveals mechanism initiating disease, in mice

March 12, 2010
UCSF scientists have discovered how a mutated gene known as Kras is able to hijack mouse cells damaged by acute pancreatitis, putting them on the path to becoming pancreatic cancer cells. The finding, they say, suggests one way in which the mutated gene -- found ...

Pancreatic Cancer Study Reveals Mechanism Initiating Disease, In Mice

March 11, 2010
UCSF scientists have discovered how a mutated gene known as Kras is able to hijack mouse cells damaged by acute pancreatitis, putting them on the path to becoming pancreatic cancer cells. ...

Pancreatic cancer study reveals mechanism initiating disease, in mice

March 11, 2010
UCSF scientists have discovered how a mutated gene known as Kras is able to hijack mouse cells damaged by acute pancreatitis, putting them on the path to becoming pancreatic cancer cells.

Depleting breast cancer-initiating cells by targeting the protein CXCR1

January 4, 2010
Recent data suggest that breast cancer is initiated and maintained by a rare population of cells within the tumor known as cancer stem cells. These cells are thought also to contribute to tumor spread and recurrence after treatment. New research has now identified a strategy to target human breast cancer ...

Tumor-initiating Cells Detected in Pten Null Prostate Cancer Model

November 12, 2009
(PhysOrg.com) -- New findings published in Cancer Research, a journal of the American Association for Cancer Research, advance the current understanding of the role of stem/progenitor cells on the initiation and progression of prostate cancer from the Pten null prostate cancer model.